Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment Pathways
<b>Background/Objectives</b>: Pulmonary arterial hypertension (PAH) is a progressive vascular disorder characterized by increased pulmonary vascular resistance, right ventricular dysfunction, and high mortality rates. Despite advancements in vasodilatory therapies, PAH remains a life-thr...
Saved in:
| Main Authors: | Masab Mansoor, Andrew F. Ibrahim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/3/600 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dysregulation of Mitochondrial in Pulmonary Hypertension-Related Right Ventricular Remodeling: Pathophysiological Features and Targeting Drugs
by: Yuehan Wang, et al.
Published: (2025-03-01) -
Pulmonary hypertension and right ventricular dysfunction as predictors of severe coronavirus infection
by: V. I. Podzolkov, et al.
Published: (2023-08-01) -
Right Ventricular Dysfunction in Lung Disease/Hypoxia‐Associated Pulmonary Hypertension
by: Hideki Shima, et al.
Published: (2025-08-01) -
Impaired right atrial function preceding right ventricular systolic dysfunction: clinical utility and long-term prognostic value in pulmonary hypertension
by: Fan Yang, et al.
Published: (2025-06-01) -
Neurotrophins in the pathogenesis of pulmonary hypertension and right ventricular dysfunction
by: E. M. Andreeva, et al.
Published: (2022-03-01)